Over the past 12‑18 months the Agarwood Powder industry trends have accelerated through a series of strategic moves. In March 2024, Indonesian leader PT Aromatika partnered with Singapore‑based biotech firm BioScent to co‑develop a high‑purity, nano‑encapsulated powder aimed at premium cosmetics, leveraging BioScent’s patented delivery technology. July 2024 saw the acquisition of Malaysia’s GreenLeaf Extracts by Thailand’s Virox Holdings for $78 million, consolidating supply chains across the ASEAN region and expanding Virox’s downstream processing capacity. In September 2024, a new cold‑press extraction line was launched by Japan’s Kiyomizu Labs, promising a 20 % increase in yield and reduced solvent residues, a key differentiator for health‑focused consumers. Regulatory shifts in the EU, effective January 2025, introduced stricter labeling requirements for fragrance allergens, prompting manufacturers to adopt transparent sourcing certifications. Meanwhile, a $15 million Series B round closed for US startup PureAgar, fueling its expansion into North American wellness retail. Collectively, these developments signal a move toward higher‑value, tech‑driven products and tighter compliance, reshaping market dynamics.